Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simona M Ceccarelli

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Bioanalysis|November 19, 2010
LC-SPE-NMR-MS: a total analysis system for bioanalysisGötz Schlotterbeck, Simona M Ceccarelli
Journal of Medicinal Chemistry|April 21, 2011
Carnitine palmitoyltransferase (CPT) modulators: a medicinal chemistry perspective on 35 years of researchSimona M Ceccarelli, Odile Chomienne, Marcel Gubler, et al.
Bioorganic & Medicinal Chemistry Letters|October 26, 2005
Discovery of N-(2-aryl-cyclohexyl) substituted spiropiperidines as a novel class of GlyT1 inhibitorsEmmanuel Pinard, Simona M Ceccarelli, Henri Stalder, et al.
Bioorganic & Medicinal Chemistry Letters|October 26, 2005
Discovery of N-(2-hydroxy-2-aryl-cyclohexyl) substituted spiropiperidines as GlyT1 antagonists with improved pharmacological profileSimona M Ceccarelli, Emmanuel Pinard, Henri Stalder, et al.
Bioorganic & Medicinal Chemistry Letters|December 27, 2006
Rational design, synthesis, and structure-activity relationship of benzoxazolones: new potent mglu5 receptor antagonists based on the fenobam structureSimona M Ceccarelli, Georg Jaeschke, Bernd Buettelmann, et al.
Bioorganic & Medicinal Chemistry Letters|June 10, 2006
Design and synthesis of 4-substituted-8-(2-phenyl-cyclohexyl)-2,8-diaza-spiro[4.5]decan-1-one as a novel class of GlyT1 inhibitors: achieving selectivity against the mu opioid and nociceptin/orphanin FQ peptide (NOP) receptorsDaniela Alberati, Simona M Ceccarelli, Synèse Jolidon, et al.
Bioorganic & Medicinal Chemistry Letters|September 24, 2016
Design and synthesis of selective, dual fatty acid binding protein 4 and 5 inhibitorsHolger Kühne, Ulrike Obst-Sander, Bernd Kuhn, et al.
Bioorganic & Medicinal Chemistry Letters|January 2, 2007
Synthesis and biological evaluation of fenobam analogs as mGlu5 receptor antagonistsGeorg Jaeschke, Richard Porter, Bernd Büttelmann, et al.
Chemmedchem|November 13, 2007
Metabolite identification via LC-SPE-NMR-MS of the in vitro biooxidation products of a lead mGlu5 allosteric antagonist and impact on the improvement of metabolic stability in the seriesSimona M Ceccarelli, Götz Schlotterbeck, Patrick Boissin, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Bioanalysis|November 19, 2010
LC-SPE-NMR-MS: a total analysis system for bioanalysisGötz Schlotterbeck, Simona M Ceccarelli
Journal of Medicinal Chemistry|April 21, 2011
Carnitine palmitoyltransferase (CPT) modulators: a medicinal chemistry perspective on 35 years of researchSimona M Ceccarelli, Odile Chomienne, Marcel Gubler, et al.
Bioorganic & Medicinal Chemistry Letters|October 26, 2005
Discovery of N-(2-aryl-cyclohexyl) substituted spiropiperidines as a novel class of GlyT1 inhibitorsEmmanuel Pinard, Simona M Ceccarelli, Henri Stalder, et al.
Bioorganic & Medicinal Chemistry Letters|October 26, 2005
Discovery of N-(2-hydroxy-2-aryl-cyclohexyl) substituted spiropiperidines as GlyT1 antagonists with improved pharmacological profileSimona M Ceccarelli, Emmanuel Pinard, Henri Stalder, et al.
Bioorganic & Medicinal Chemistry Letters|December 27, 2006
Rational design, synthesis, and structure-activity relationship of benzoxazolones: new potent mglu5 receptor antagonists based on the fenobam structureSimona M Ceccarelli, Georg Jaeschke, Bernd Buettelmann, et al.
Bioorganic & Medicinal Chemistry Letters|June 10, 2006
Design and synthesis of 4-substituted-8-(2-phenyl-cyclohexyl)-2,8-diaza-spiro[4.5]decan-1-one as a novel class of GlyT1 inhibitors: achieving selectivity against the mu opioid and nociceptin/orphanin FQ peptide (NOP) receptorsDaniela Alberati, Simona M Ceccarelli, Synèse Jolidon, et al.
Bioorganic & Medicinal Chemistry Letters|September 24, 2016
Design and synthesis of selective, dual fatty acid binding protein 4 and 5 inhibitorsHolger Kühne, Ulrike Obst-Sander, Bernd Kuhn, et al.
Bioorganic & Medicinal Chemistry Letters|January 2, 2007
Synthesis and biological evaluation of fenobam analogs as mGlu5 receptor antagonistsGeorg Jaeschke, Richard Porter, Bernd Büttelmann, et al.
Chemmedchem|November 13, 2007
Metabolite identification via LC-SPE-NMR-MS of the in vitro biooxidation products of a lead mGlu5 allosteric antagonist and impact on the improvement of metabolic stability in the seriesSimona M Ceccarelli, Götz Schlotterbeck, Patrick Boissin, et al.
Pageof 1